Back
ESC Premium Access

Percutaneous transluminal alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy and drug refractory symptoms: intermediate-term outcomes of a prospective cohort.

Session: Poster Session 5 - Non-coronary cardiac interventions
Topic: Noncoronary Cardiac Intervention, Other
Speaker: Ms M. Plaza Martin (Valladolid, ES)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Ms Maria Plaza Martin

UNIVERSITY HOSPITAL CLINIC, Valladolid (Spain)
2 presentations
0 follower

13 more presentations in this session

Percutaneous balloon mitral valvuloplasty in pregnant women with severe mitral stenosis: a review of literature and meta-analysis

Speaker: Doctor F. Fioravanti (Milan, IT)

Access
Abstract
Like
Thumbnail

Safety and efficacy of left atrial appendage occlusion guided by CT-scan and intracardiac echocardiography from the left atrium.

Speaker: Mr T. Pommier (Dijon, FR)

Access
Abstract
Slides
Like
Thumbnail

Impact of left atrial appendage morphology on procedural characteristics: A two center experience with the Amplatzer Amulet Device

Speaker: Assistant Professor B. Al-Kassou (Bonn, DE)

Access
Abstract
Slides
Like
Thumbnail

Infective endocarditis following transcatheter aortic valve implantation; a single centre experience out to 10 years

Speaker: Doctor P. Brennan (Belfast, GB)

Access
Abstract
Slides
Like
Thumbnail

Short- and long-term mortality in patients with diabetes mellitus after TAVR: Results of an international multicenter registry.

Speaker: Assistant Professor V. Veulemans (Duesseldorf, DE)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 5 - Non-coronary cardiac interventions

Speakers: Ms M. Plaza Martin, Doctor F. Fioravanti, Mr T. Pommier, Assistant Professor B. Al-Kassou, Doctor P. Brennan...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources